Mark Allen
Co-Founder and CEO at Elevian
Dr. Allen is a serial entrepreneur and executive, with experience leading organizations from inception to profitable growth to successful exit.
Dr. Allen has a BS in Applied Physics from Columbia University and an MD from UCLA.
During his medical training, he developed one of the first web-based clinical decision support systems to guide ER physicians to make the right patient care decisions. Dr. Allen founded Corticon to bring this new technology to market. Under Dr. Allen’s leadership as CEO, Corticon became one of the leading commercial rules engine software products, powering automated decision-making in healthcare, insurance, banking, retail and manufacturing.
In early 2017, excited by the recent scientific progress in the longevity industry, Dr. Allen left Progress with a passion to extend healthy lifespan.
He partnered with Elevian’s scientific co-founders at Harvard to develop their GDF11 technology into new drugs, recruiting and leading a team of leading scientists and drug development veterans. An active member of YPO since 2009, Dr. Allen serves on the board of YPO San Francisco Gold.
Visit website: https://www.elevian.com/mark-allen
See also: Elevian - Young blood medicine maker for body rejuvenation.
Details last updated 25-Nov-2020
Mark Allen News
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Elevian has secured $40 million for anti-aging diseases and heart stroke
FierceBiotech - 17-Sep-2021
$40 million for clinical research, lead program-stroke recovery focuses GDF11
Read more...Elevian raises $15M in preclinical work towards clinical antiaging
FierceBiotech - 24-Nov-2020
rGDF11 in clinic targets multiple age related disease therapies
Read more...